A court in Hunan Province, China has found GlaxoSmithKline’s subsidiary, GSK China Investment Co Ltd (GSKCI), guilty of bribing non-government personnel and ordered it to pay a fine of £297 million, the UK company announced on 19 September. ---Subscribe to MedNous to access this article--- Company News